Lobby organisation
The Employers' Union of Innovative Pharmaceutical Companies
Business group · Health & pharma · HQ: Poland · Transparency Register entry
As of 8 October 2026, The Employers' Union of Innovative Pharmaceutical Companies appears in 3 declared MEP meetings (2 different MEPs), most often with European People's Party.
In their own words
“The Employers' Union of Innovative Pharmaceutical Companies INFARMA represents 24 leading pharmaceutical companies engaged in research and development activities and the production of innovative medicines.”
Read the rest of the statementShow less of the statement
“INFARMA’s objective is taking initiatives which positively influence the creation of system solutions in the field of healthcare and promoting innovation resulting from research and original medicinal products in accordance with the principles of medicine based on evidence. Such solutions should allow patients access to modern and the most effective treatments so that Polish norms of treatment meet the global standards. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high-quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2025. Bar length is relative to its busiest year (2 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 30 Sep 2025 | Waldemar Buda | Pakiet farmaceutyczny, analiza zmian rynku badań klinicznych |
| 5 Nov 2024 | Adam Jarubas | Reforma rynku farmaceutycznego UE |
| 5 Mar 2024 | Adam Jarubas | Reforma rynku farmaceutycznego UE |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.